219 related articles for article (PubMed ID: 33340078)
1. Isolated lip dermatitis (atopic cheilitis), successfully treated with topical tacrolimus 0.03.
Georgakopoulou E; Loumou P; Grigoraki A; Panagiotopoulos A
Med Oral Patol Oral Cir Bucal; 2021 May; 26(3):e357-e360. PubMed ID: 33340078
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of plasma cell cheilitis with topical tacrolimus: report of two cases.
Hanami Y; Motoki Y; Yamamoto T
Dermatol Online J; 2011 Feb; 17(2):6. PubMed ID: 21382289
[TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus with different frequency for exfoliative cheilitis: a pilot study.
Zhang QQ; Xu P; Sun C; Liu LJ; Jiang WW
J Dermatolog Treat; 2022 Feb; 33(1):550-554. PubMed ID: 32431191
[TBL] [Abstract][Full Text] [Related]
4. Plasma cell cheilitis, successfully treated with topical 0.03% tacrolimus ointment.
Jin SP; Cho KH; Huh CH
J Dermatolog Treat; 2010 May; 21(3):130-2. PubMed ID: 19707925
[TBL] [Abstract][Full Text] [Related]
5. Exfoliative cheilitis successfully treated with topical tacrolimus.
Connolly M; Kennedy C
Br J Dermatol; 2004 Jul; 151(1):241-2. PubMed ID: 15270904
[No Abstract] [Full Text] [Related]
6. Tacrolimus 0.03% ointment treatment in exfoliative cheilitis: A randomised controlled clinical trial and monitoring blood concentration.
Liu J; Shi L; Wang X; Wu F; Hu M; He J; Lin M; Wang H; Zhou H
J Oral Pathol Med; 2021 Feb; 50(2):251-259. PubMed ID: 33220069
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment with 308-nm monochromatic excimer light and subsequent tacrolimus 0.03% ointment in refractory plasma cell cheilitis.
Yoshimura K; Nakano S; Tsuruta D; Ohata C; Hashimoto T
J Dermatol; 2013 Jun; 40(6):471-4. PubMed ID: 23621817
[TBL] [Abstract][Full Text] [Related]
8. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan.
Nakagawa H
Clin Drug Investig; 2006; 26(5):235-46. PubMed ID: 17163257
[TBL] [Abstract][Full Text] [Related]
10. Psoriatic cheilitis: a report of 2 cases treated successfully with topical tacrolimus and a review of the literature.
Apalla Z; Sotiriou E; Trigoni A; Ioannides D
Actas Dermosifiliogr; 2015 Oct; 106(8):687-9. PubMed ID: 26164836
[No Abstract] [Full Text] [Related]
11. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
12. Topical tacrolimus treatment of atopic eyelid disease.
Rikkers SM; Holland GN; Drayton GE; Michel FK; Torres MF; Takahashi S
Am J Ophthalmol; 2003 Mar; 135(3):297-302. PubMed ID: 12614745
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
Breuer K; Werfel T; Kapp A
Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
Cheer SM; Plosker GL
Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.
Ellis CN; Drake LA; Prendergast MM; Abramovits W; Boguniewicz M; Daniel CR; Lebwohl M; Paller AS; Stevens SR; Whitaker-Worth DL; Tong KB
J Am Acad Dermatol; 2003 Apr; 48(4):553-63. PubMed ID: 12664019
[TBL] [Abstract][Full Text] [Related]
16. [Tacrolimus ointment in the management of atopic keratoconjunctivitis].
Benaim D; Tétart F; Bauvin O; Delcampe A; Joly P; Muraine M; Gueudry J
J Fr Ophtalmol; 2019 May; 42(5):435-440. PubMed ID: 30935698
[TBL] [Abstract][Full Text] [Related]
17. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
18. Acute actinic cheilitis-like chemical irritant reaction following accidental contact with ethylene glycol-favorable response to topical 1% pimecrolimus cream: a case report.
Erkek E; Kazkayasi M; Bozdogan O
Cutan Ocul Toxicol; 2008; 27(2):91-5. PubMed ID: 18568894
[TBL] [Abstract][Full Text] [Related]
19. Topical tacrolimus for the treatment of inflammatory skin diseases.
Assmann T; Homey B; Ruzicka T
Expert Opin Pharmacother; 2001 Jul; 2(7):1167-75. PubMed ID: 11583067
[TBL] [Abstract][Full Text] [Related]
20. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group.
Boguniewicz M; Fiedler VC; Raimer S; Lawrence ID; Leung DY; Hanifin JM
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):637-44. PubMed ID: 9802373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
